Effectively managing malignancy in patients with Inflammatory Bowel Disease (IBD) requires a comprehensive and proactive approach. The latest guidance from…
Browsing: Clinical Updates
Dr. Brent Neuschwander-Tetri discusses the latest AASLD guidance on diagnosing and treating Metabolic Associated Steatotic Liver Disease (MASLD). This new…
A recent article on Medscape explores the potential of circulating tumor DNA (ctDNA) to guide clinical decisions in gastrointestinal cancers.…
Celiac disease, affecting approximately 1% of the US population, is an immune-mediated response to gluten, leading to small bowel mucosa…
Researchers are exploring the use of lab-grown mini guts to identify the most effective treatments for Crohn’s disease, potentially revolutionizing…
The FDA has cleared the first rapid diagnostic Hepatitis C RNA test for point-of-care settings, marking a significant advancement in…
Recent research on inflammatory bowel disease (IBD) highlights the potential of fecal microbiota transplants (FMT) to modify the gut microbiome…
A new immunotherapy for colorectal cancer has shown promising results in an early-phase clinical trial. The treatment leverages the body’s…
Key Insights:
Key Insights The identification of a new biological pathway by researchers holds promise for developing more effective treatments for bowel…